Search
Menu
Home
HTB
2025
February
February 2025
Contents
Special reports
Country update from Nigeria: current impact on HIV services
News and resources linked to changes in US policy on international aid
Impact of US elections and executive orders on global health: waiver covers PEPFAR with restrictions
Antiretrovirals
Lenacapavir for PrEP submitted to EMA for EU and global use
Treatment access
Responses to the UK government slashing international aid by 40%
Deleted words from official documents: LGBTQ, diversity, inclusion, transgender
IAS public letter: Why HIV could be poised for a monumental comeback
Weight, diabetes, metabolic complications
Semaglutide reduces alcohol and cigarette use in a randomised phase 2 study
mpox
New mpox vaccination sites open in the UK
Africa CDC special briefing on mpox and the impact of conflict
HTB RSS
Early access
The RIO study: Q&A about controlling HIV with bNAbs
21 April 2025
Lenacapavir EAP in the UK closed to new referrals: NHS England and Gilead fail to agree a price after more than two years
20 April 2025
Viral failure on CAB/RPV-LA: overcoming drug resistance with second-generation INSTIs
13 April 2025
Lancet HIV recognises Transgender Day of Visibility and the importance of gender-affirming hormones in HIV care
3 April 2025
All early access reports
Current issues
April 2025
March 2025
February 2025
Back issues
Special report
Lancet HIV recognises Transgender Day of Visibility and the importance of gender-affirming hormones in HIV care
3 April 2025
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage
Donate